Healthy Skepticism Library item: 4500

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Re: the promotion of nimodipine
1992 Sep

Abstract:

In Pakistan and Panama the subsidiaries of Bayer are marketing nimodipine for a variety of cerebrovascular conditions including organic brain syndromes and reduced capacity for concentration. The scientific literature does not support the use of this product for these conditions.

Keywords:
*analysis/Pakistan/Panama/developing countries/Bayer/nimodipine/neurologic drugs/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: NEUROLOGIC DISEASES